1. GLOBOCAN 2020: New Global Cancer Data|UICC. Retrieved on September 30, 2021, from https://www.uicc.org/news/globocan-2020-new-global-cancer-data
2. Roodman, G. D. (2004). Mechanisms of bone metastasis. New England Journal of Medicine, 350(16), 1655–1664. https://doi.org/10.1056/nejmra030831
3. D’Oronzo, S., Coleman, R., Brown, J., & Silvestris, F. (2019, April 01). Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management. Journal of Bone Oncology, 15. Elsevier GmbH, p. 004. https://doi.org/10.1016/j.jbo.2018.10.004
4. Coleman, R. E. (2001). Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treatment Reviews, 27(3), 165–176. https://doi.org/10.1053/ctrv.2000.0210
5. Coleman, R. E., Roodman, S., Body, S., & Vessella. (2006, October 15). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clinical Cancer Research, 12(20), PART 2. https://doi.org/10.1158/1078-0432.CCR-06-0931